DaVita Slides as Solid Q2 Results Fail to Lift Full-Year Outlook

DaVita Inc. (DVA) is down 9.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied less to a weak quarter and more to investor expectations heading into the report. DaVita posted higher revenue, earnings, and cash flow in the second quarter, but it kept full-year 2026 guidance unchanged after raising it in the first quarter, which may have disappointed a market that had already priced in more upside. Sequential pressure in revenue per treatment and higher general and administrative spending may also have added to the cautious reaction.

Details:

DaVita reported second-quarter 2026 revenue of $3.554 billion, operating income of $579 million, and diluted earnings per share of $4.02.

Full-year 2026 guidance stayed at adjusted operating income of $2.15 billion to $2.25 billion, adjusted diluted EPS of $14.10 to $15.20, and free cash flow of $1.0 billion to $1.25 billion, unchanged from the outlook provided after first-quarter results.

U.S. dialysis revenue per treatment was $415.87 in the second quarter, down from $417.59 in the first quarter, with the company pointing to payor mix changes and normal fluctuations.

General and administrative expense rose to $331 million from $320 million in the prior quarter, while DaVita also added a $500 million Term Loan B-2 tranche and continued aggressive share repurchases.

Sources:

DaVita, SEC, MarketBeat

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$DVA Insider Trading Activity

$DVA insiders have traded $DVA stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $DVA stock by insiders over the last 6 months:

HATHAWAY INC BERKSHIRE sold 1,220,376 shares for an estimated $182,864,678
JAVIER RODRIGUEZ (Chief Executive Officer) has made 0 purchases and 2 sales selling 69,407 shares for an estimated $14,532,108.
DAVID PAUL MAUGHAN (Chief Operating Officer, DKC) has made 0 purchases and 2 sales selling 20,529 shares for an estimated $4,089,742.
KATHLEEN ALYCE WATERS (Chief Legal & Pub. Affairs Off) has made 0 purchases and 2 sales selling 15,405 shares for an estimated $3,210,376.
JAMES O HEARTY (Chief Compliance Officer) sold 15,000 shares for an estimated $2,909,745

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive DVA Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$DVA Hedge Fund Activity

We have seen 286 institutional investors add shares of $DVA stock to their portfolio, and 264 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BERKSHIRE HATHAWAY INC removed 1,658,480 shares (-5.2%) from their portfolio in Q1 2026, for an estimated $252,470,410
MILLENNIUM MANAGEMENT LLC removed 797,374 shares (-93.5%) from their portfolio in Q1 2026, for an estimated $121,384,244
WOODLINE PARTNERS LP added 452,979 shares (+inf%) to their portfolio in Q1 2026, for an estimated $68,956,993
GATES CAPITAL MANAGEMENT, INC. removed 452,477 shares (-38.5%) from their portfolio in Q1 2026, for an estimated $68,880,573
SQUAREPOINT OPS LLC removed 391,631 shares (-79.6%) from their portfolio in Q1 2026, for an estimated $59,617,987
AQR CAPITAL MANAGEMENT LLC added 363,574 shares (+782.9%) to their portfolio in Q1 2026, for an estimated $55,346,870
CITADEL ADVISORS LLC added 357,937 shares (+99.0%) to their portfolio in Q1 2026, for an estimated $54,488,749

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$DVA Government Contracts

We have seen $260,941,511 of award payments to $DVA over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

EXPRESS REPORT: FY 26 NOVEMBER NDSC EXPRESS REPORT: $121,425,309
EXPRESS REPORT: FY 26 OCTOBER NDSC EXPRESS REPORT: $26,893,447
EXPRESS REPORT: FY 25 AUGUST NDSC EXPRESS REPORT: $26,812,687
EXPRESS REPORT: FY 25 SEPTEMBER NDSC EXPRESS REPORT: $26,790,486
EXPRESS REPORT: FY 25 JULY NDSC EXPRESS REPORT: $26,265,332

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$DVA Congressional Stock Trading

Members of Congress have traded $DVA stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $DVA stock by members of Congress over the last 6 months:

SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$DVA Analyst Ratings

Wall Street analysts have issued reports on $DVA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Deutsche Bank issued a "Buy" rating on 05/06/2026

To track analyst ratings and price targets for $DVA, check out Quiver Quantitative's $DVA forecast page.

$DVA Price Targets

Multiple analysts have issued price targets for $DVA recently. We have seen 5 analysts offer price targets for $DVA in the last 6 months, with a median target of $218.0.

Here are some recent targets:

Andrew Mok from Barclays set a target price of $218.0 on 07/09/2026
Ryan Langston from TD Cowen set a target price of $201.0 on 05/11/2026
David Macdonald from Truist Securities set a target price of $205.0 on 05/08/2026
A.J. Rice from UBS set a target price of $235.0 on 05/07/2026
Pito Chickering from Deutsche Bank set a target price of $220.0 on 05/06/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.